We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
Cap. Flow
+$575M
Cap. Flow %
3.88%
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 9.79%
2 Consumer Discretionary 5%
3 Healthcare 4.52%
4 Financials 4.2%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVR icon
2451
Invesco Senior Income Trust
VVR
$457M
$41K ﹤0.01%
11,167
-1,271
-10% -$4.53K
COTY icon
2452
Coty
COTY
$2.43B
$38K ﹤0.01%
14,020
-3,378
-19% -$12.8K
SMSI icon
2453
Smith Micro Software
SMSI
$17M
$38K ﹤0.01%
253
+2
+0.8% +$315
WPRT
2454
Westport Fuel Systems
WPRT
$34.6M
$38K ﹤0.01%
2,308
+550
+31% +$9.07K
AWH
2455
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$38K ﹤0.01%
+823
New +$42.2K
ENDP
2456
DELISTED
Endo International plc
ENDP
$38K ﹤0.01%
11,505
-426
-4% -$1.37K
NTRP
2457
DELISTED
Neurotrope, Inc. Common
NTRP
$38K ﹤0.01%
+34,370
New +$39.5K
EXK
2458
Endeavour Silver
EXK
$3.14B
$37K ﹤0.01%
+10,645
New +$39.4K
SUPV
2459
Grupo Supervielle
SUPV
$725M
$37K ﹤0.01%
+20,717
New +$52.4K
DMK
2460
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$37K ﹤0.01%
+669
New +$39.7K
CARM
2461
DELISTED
Carisma Therapeutics
CARM
$35K ﹤0.01%
1,245
CLNE icon
2462
Clean Energy Fuels
CLNE
$384M
$35K ﹤0.01%
14,009
-1,200
-8% -$3.12K
CRESY
2463
Cresud
CRESY
$759M
$35K ﹤0.01%
12,994
+1,559
+14% +$5.08K
OXY.WS icon
2464
Occidental Petroleum Corp Warrants
OXY.WS
$34.4B
$35K ﹤0.01%
+11,696
New +$37.4K
THER
2465
DELISTED
THERATECHNOLOGIES INC COM
THER
$35K ﹤0.01%
15,733
+1,192
+8% +$2.65K
AMTX icon
2466
Aemetis
AMTX
$126M
$32K ﹤0.01%
10,000
CPIX icon
2467
Cumberland Pharmaceuticals
CPIX
$119M
$32K ﹤0.01%
10,000
NNDM
2468
Nano Dimension
NNDM
$343M
$32K ﹤0.01%
11,200
+1,200
+12% +$2.29K
SOHO
2469
DELISTED
Sotherly Hotels
SOHO
$32K ﹤0.01%
17,918
-1,254
-7% -$2.69K
TLPH icon
2470
Talphera
TLPH
$72.7M
$30K ﹤0.01%
1,064
+300
+39% +$7.44K
TCRT icon
2471
Alaunos Therapeutics
TCRT
$4.88M
$29K ﹤0.01%
+78
New +$34.5K
DXYN
2472
DELISTED
Dixie Group Inc
DXYN
$29K ﹤0.01%
32,007
KDNY
2473
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$29K ﹤0.01%
+2,400
New +$32.2K
HTZ
2474
DELISTED
Hertz Global Holdings, Inc.
HTZ
$29K ﹤0.01%
25,981
+703
+3% +$1.01K
REFR icon
2475
Research Frontiers
REFR
$16.8M
$28K ﹤0.01%
+10,500
New +$30.4K

Similar funds

Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
  • Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
  • Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
  • Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.